PAX2 expression in ovarian cancer

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 6090-6105

  Song, Huijuan ^a,b   Kwan, Suet Yan ^a,b   Izaguirre, Daisy I ^a,b   Zu, Zhifei ^a   Tsang, Yvonne T ^a   Tung, Celestine S ^a   King, Erin R ^a   Mok, Samuel C ^a,b   Gershenson, David M ^a   Wong, Kwong Kwok ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

G0S2; GREM1; ovarian cancer; PAX2; ShRNA; WFDC1

Indexed keywords

LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR PAX2;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN RMUGL; CELL STRAIN TOV21G; CONTROLLED STUDY; G0S2 GENE; GENE; GENE EXPRESSION PROFILING; GENE TARGETING; GREM1 GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OVARY CANCER; PAX2 GENE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; WFDC1 GENE;

EID: 84875502875     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14036090     Document Type: Article

References (45)

1. Eccles, M.R.; He, S.; Legge, M.; Kumar, R.; Fox, J.; Zhou, C.; French, M.; Tsai, R.W. PAX genes in development and disease: The role of PAX2 in urogenital tract development. Int. J. Dev. Biol. 2002, 46, 535-544.
2. Chan-Ling, T.; Chu, Y.; Baxter, L.; Weible Ii, M.; Hughes, S. In vivo characterization of astrocyte precursor cells (APCs) and astrocytes in developing rat retinae: Differentiation, proliferation, and apoptosis. Glia 2009, 57, 39-53.
3. Wasco, M.J.; Pu, R.T. Comparison of PAX-2, RCC antigen, and antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma by fine-needle aspiration. Diagn. Cytopathol. 2008, 36, 568-573.
4. Sims-Lucas, S.; Cusack, B.; Baust, J.; Eswarakumar, V.P.; Masatoshi, H.; Takeuchi, A.; Bates, C.M. Fgfr1 and the IIIc isoform of Fgfr2 play critical roles in the metanephric mesenchyme mediating early inductive events in kidney development. Dev. Dyn. 2011, 240, 240-249.
5. Abdel-Hakeem, A.K.; Henry, T.Q.; Magee, T.R.; Desai, M.; Ross, M.G.; Mansano, R.Z.; Torday, J.S.; Nast, C.C. Mechanisms of impaired nephrogenesis with fetal growth restriction: Altered renal transcription and growth factor expression. Am. J. Obstet. Gynecol. 2008, 199, 252. e251-252. e257.
6. Burton, Q.; Cole, L.K.; Mulheisen, M.; Chang, W.; Wu, D.K. The role of Pax2 in mouse inner ear development. Dev. Biol. 2004, 272, 161-175.
7. Ritz-Laser, B.; Estreicher, A.; Gauthier, B.; Philippe, J. The paired homeodomain transcription factor Pax-2 is expressed in the endocrine pancreas and transactivates the glucagon gene promoter. J. Biol. Chem. 2000, 275, 32708-32715.
8. Fletcher, J.; Hu, M.; Berman, Y.; Collins, F.; Grigg, J.; McIver, M.; Juppner, H.; Alexander, S.I. Multicystic dysplastic kidney and variable phenotype in a family with a novel deletion mutation of PAX2. J. Am. Soc. Nephrol. 2005, 16, 2754-2761.
9. Sanyanusin, P.; Schimmenti, L.A.; McNoe, L.A.; Ward, T.A.; Pierpont, M.E.; Sullivan, M.J.; Dobyns, W.B.; Eccles, M.R. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nat. Genet. 1995, 9, 358-364.
10. Soofi, A.; Levitan, I.; Dressler, G.R. Two novel EGFP insertion alleles reveal unique aspects of Pax2 function in embryonic and adult kidneys. Dev. Biol. 2012, 365, 241-250.
11. Soukkarieh, C.; Agius, E.; Soula, C.; Cochard, P. Pax2 regulates neuronal-glial cell fate choice in the embryonic optic nerve. Dev. Biol. 2007, 303, 800-813.
12. Li, C.G.; Eccles, M.R. PAX genes in cancer; Friends or foes? Front. Genet. 2012, 3, 6.
13. Weber, S.; Taylor, J.C.; Winyard, P.; Baker, K.F.; Sullivan-Brown, J.; Schild, R.; Knuppel, T.; Zurowska, A.M.; Caldas-Alfonso, A.; Litwin, M.; et al. SIX2 and BMP4 mutations associate with anomalous kidney development. J. Am. Soc. Nephrol. 2008, 19, 891-903.
14. Dressler, G.R.; Woolf, A.S. Pax2 in development and renal disease. Int. J. Dev. Biol. 1999, 43, 463-468.
15. Tong, G.X.; Chiriboga, L.; Hamele-Bena, D.; Borczuk, A.C. Expression of PAX2 in papillary serous carcinoma of the ovary: Immunohistochemical evidence of fallopian tube or secondary Mullerian system origin? Mod. Pathol. 2007, 20, 856-863.
16. Gnarra, J.R.; Dressler, G.R. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res. 1995, 55, 4092-4098.
17. Khoubehi, B.; Kessling, A.M.; Adshead, J.M.; Smith, G.L.; Smith, R.D.; Ogden, C.W. Expression of the developmental and oncogenic PAX2 gene in human prostate cancer. J. Urol. 2001, 165, 2115-2120.
18. Silberstein, G.B.; Dressler, G.R.; van Horn, K. Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth. Oncogene 2002, 21, 1009-1016.
19. Tung, C.S.; Mok, S.C.; Tsang, Y.T.; Zu, Z.; Song, H.; Liu, J.; Deavers, M.T.; Malpica, A.; Wolf, J.K.; Lu, K.H.; Gershenson, D.M.; Wong, K.K. PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Mod. Pathol. 2009, 22, 1243-1250.
20. Muratovska, A.; Zhou, C.; He, S.; Goodyer, P.; Eccles, M.R. Paired-box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 2003, 22, 7989-7997.
21. Doberstein, K.; Pfeilschifter, J.; Gutwein, P. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma. Carcinogenesis 2011, 32, 1713-1723.
22. Quick, C.M.; Ning, G.; Bijron, J.; Laury, A.; Wei, T.S.; Chen, E.Y.; Vargas, S.O.; Betensky, R.A.; McKeon, F.D.; Xian, W.; Crum, C.P. PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer. Mod. Pathol. 2012, 25, 449-455.
23. Roh, M.H.; Yassin, Y.; Miron, A.; Mehra, K.K.; Mehrad, M.; Monte, N.M.; Mutter, G.L.; Nucci, M.R.; Ning, G.; McKeon, F.D.; et al. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Mod. Pathol. 2010, 23, 1316-1324.
24. Chen, E.Y.; Mehra, K.; Mehrad, M.; Ning, G.; Miron, A.; Mutter, G.L.; Monte, N.; Quade, B.J.; McKeon, F.D.; Yassin, Y.; Xian, W.; Crum, C.P. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube. J. Pathol. 2010, 222, 110-116.
25. Monte, N.M.; Webster, K.A.; Neuberg, D.; Dressler, G.R.; Mutter, G.L. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Cancer Res. 2010, 70, 6225-6232.
26. Geback, T.; Schulz, M.M.; Koumoutsakos, P.; Detmar, M. TScratch: A novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 2009, 46, 265-274.
27. Hong, B.; Lui, V.W.; Hui, E.P.; Lu, Y.; Leung, H.S.; Wong, E.Y.; Cheng, S.H.; Ng, M.H.; Mills, G.B.; Chan, A.T. Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1. Biochem. Pharmacol. 2010, 79, 842-852.
28. Kurman, R.J.; Shih Ie, M. The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory. Am. J. Surg. Pathol. 2010, 34, 433-443.
29. Wiegand, K.C.; Shah, S.P.; Al-Agha, O.M.; Zhao, Y.; Tse, K.; Zeng, T.; Senz, J.; McConechy, M.K.; Anglesio, M.S.; Kalloger, S.E.; et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 2010, 363, 1532-1543.
30. Saifudeen, Z.; Liu, J.; Dipp, S.; Yao, X.; Li, Y.; McLaughlin, N.; Aboudehen, K.; El-Dahr, S.S. A p53-Pax2 pathway in kidney development: Implications for nephrogenesis. PLoS One 2012, 7, e44869.
31. Zhang, H.S.; Yan, B.; Li, X.B.; Fan, L.; Zhang, Y.F.; Wu, G.H.; Li, M.; Fang, J. Pax2 induces expression of Cyclin D1 through activating AP-1 and promotes proliferation of colon cancer cells. J. Biol. Chem. 2012, 287, 44164-44172.
32. Hueber, P.A.; Iglesias, D.; Chu, L.L.; Eccles, M.; Goodyer, P. In vivo validation of PAX2 as a target for renal cancer therapy. Cancer Lett. 2008, 265, 148-155.
33. Russell, L.; Forsdyke, D.R. A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated. DNA Cell Biol. 1991, 10, 581-591.
34. Cristillo, A.D.; Heximer, S.P.; Russell, L.; Forsdyke, D.R. Cyclosporin A inhibits early mRNA expression of G0/G1 switch gene 2 (G0S2) in cultured human blood mononuclear cells. DNA Cell Biol. 1997, 16, 1449-1458.
35. Welch, C.; Santra, M.K.; El-Assaad, W.; Zhu, X.; Huber, W.E.; Keys, R.A.; Teodoro, J.G.; Green, M.R. Identification of a protein, G0S2, that lacks Bcl-2 homology domains and interacts with and antagonizes Bcl-2. Cancer Res. 2009, 69, 6782-6789.
36. Bouchard, D.; Morisset, D.; Bourbonnais, Y.; Tremblay, G.M. Proteins with whey-acidic-protein motifs and cancer. Lancet Oncol. 2006, 7, 167-174.
37. Madar, S.; Brosh, R.; Buganim, Y.; Ezra, O.; Goldstein, I.; Solomon, H.; Kogan, I.; Goldfinger, N.; Klocker, H.; Rotter, V. Modulated expression of WFDC1 during carcinogenesis and cellular senescence. Carcinogenesis 2009, 30, 20-27.
38. Hsu, D.R.; Economides, A.N.; Wang, X.; Eimon, P.M.; Harland, R.M. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol. Cell 1998, 1, 673-683.
39. Mulvihill, M.S.; Kwon, Y.W.; Lee, S.; Fang, L.T.; Choi, H.; Ray, R.; Kang, H.C.; Mao, J.H.; Jablons, D.; Kim, I.J. Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells. PLoS One 2012, 7, e42264.
40. Chen, B.; Athanasiou, M.; Gu, Q.; Blair, D.G. Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation. Biochem. Biophys. Res. Commun. 2002, 295, 1135-1141.
41. Zhang, Z.; Huang, L.; Zhao, W.; Rigas, B. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: Anticancer effects in vitro and in vivo. Cancer Res. 2010, 70, 2379-2388.
42. Gokden, N.; Kemp, S.A.; Gokden, M. The utility of Pax-2 as an immunohistochemical marker for renal cell carcinoma in cytopathology. Diagn. Cytopathol. 2008, 36, 473-477.
43. Li, C. Automating dChip: Toward reproducible sharing of microarray data analysis. BMC Bioinform. 2008, 9, 231.
44. Park, D.C.; Yeo, S.G.; Wilson, M.R.; Yerbury, J.J.; Kwong, J.; Welch, W.R.; Choi, Y.K.; Birrer, M.J.; Mok, S.C.; Wong, K.K. Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer. Neoplasia 2008, 10, 964-972.
45. Baby, J.; Pickering, B.F.; Vashisht Gopal, Y.N.; van Dyke, M.W. Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines. Cancer Lett. 2007, 255, 85-94.